163 related articles for article (PubMed ID: 31551033)
1. T cell-specific STAT3 deficiency abrogates lupus nephritis.
Yoshida N; He F; Kyttaris VC
Lupus; 2019 Oct; 28(12):1468-1472. PubMed ID: 31551033
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
Edwards LJ; Mizui M; Kyttaris V
Clin Immunol; 2015 Jun; 158(2):221-30. PubMed ID: 25869298
[TBL] [Abstract][Full Text] [Related]
3. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
5. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
Xia W; Eltrich N; Vielhauer V
Front Immunol; 2024; 15():1377913. PubMed ID: 38799420
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y
Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018
[TBL] [Abstract][Full Text] [Related]
8. Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.
Kluger MA; Melderis S; Nosko A; Goerke B; Luig M; Meyer MC; Turner JE; Meyer-Schwesinger C; Wegscheid C; Tiegs G; Stahl RA; Panzer U; Steinmetz OM
Kidney Int; 2016 Jan; 89(1):158-66. PubMed ID: 26466322
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
11. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration.
Harada T; Kyttaris V; Li Y; Juang YT; Wang Y; Tsokos GC
Autoimmunity; 2007 Feb; 40(1):1-8. PubMed ID: 17364491
[TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
14. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.
Kanapathippillai P; Hedberg A; Fenton CG; Fenton KA
Cytokine; 2013 May; 62(2):244-52. PubMed ID: 23561928
[TBL] [Abstract][Full Text] [Related]
15. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
[TBL] [Abstract][Full Text] [Related]
16. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
18. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.
Yamada M; Yagita H; Inoue H; Takanashi T; Matsuda H; Munechika E; Kanamaru Y; Shirato I; Tomino Y; Matushima K; Okumura K; Hashimoto H
Arthritis Rheum; 2002 Mar; 46(3):735-40. PubMed ID: 11920409
[TBL] [Abstract][Full Text] [Related]
19. PKK deficiency in B cells prevents lupus development in Sle lupus mice.
Oleksyn D; Zhao J; Vosoughi A; Zhao JC; Misra R; Pentland AP; Ryan D; Anolik J; Ritchlin C; Looney J; Anandarajah AP; Schwartz G; Calvi LM; Georger M; Mohan C; Sanz I; Chen L
Immunol Lett; 2017 May; 185():1-11. PubMed ID: 28274793
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.
Chen SY; Liu MF; Kuo PY; Wang CR
Clin Rheumatol; 2019 May; 38(5):1361-1366. PubMed ID: 30767092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
